Patents by Inventor Padmanabh P. Bhatt

Padmanabh P. Bhatt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABILIZED FORMULATIONS OF CNS COMPOUNDS
    Publication number: 20150086629
    Abstract: Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone.
    Type: Application
    Filed: April 25, 2014
    Publication date: March 26, 2015
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Rong-Kun Chang, Michael L. Vieira, Likan LIANG, Padmanabh P. BHATT, Austin B. HUANG, Sachin V. PATEL
  • ENHANCED IMMEDIATE RELEASE FORMULATIONS OF TOPIRAMATE
    Publication number: 20150024055
    Abstract: The present invention provides enhanced immediate release formulations of topiramate, in which 80% of the active ingredient is released in the period of time of not more than 30 min. These formulations may be advantageously used for the treatment of acute neurological conditions, such as migraine.
    Type: Application
    Filed: October 6, 2014
    Publication date: January 22, 2015
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Padmanabh P. BHATT, Hua WANG
  • SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE
    Publication number: 20150017249
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Application
    Filed: September 29, 2014
    Publication date: January 15, 2015
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Hua WANG, Padmanabh P. BHATT, Michael L. VIEIRA
  • Sustained-release formulations of topiramate
    Patent number: 8889191
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: November 18, 2014
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • Sustained-release formulations of topiramate
    Patent number: 8877248
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Grant
    Filed: July 14, 2014
    Date of Patent: November 4, 2014
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE
    Publication number: 20140322343
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Application
    Filed: July 14, 2014
    Publication date: October 30, 2014
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • OSMOTIC DRUG DELIVERY SYSTEM
    Publication number: 20140303252
    Abstract: An oral osmotic pharmaceutical delivery system comprises a highly water-soluble drug exhibiting an erratic or an incomplete release profile when formulated in a elementary osmotic pump delivery system and at least one release enhancing agent.
    Type: Application
    Filed: April 30, 2014
    Publication date: October 9, 2014
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Argaw Kidane, Padmanabh P. Bhatt
  • Modified release preparations containing oxcarbazepine and derivatives thereof
    Patent number: 8821930
    Abstract: Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.
    Type: Grant
    Filed: December 11, 2013
    Date of Patent: September 2, 2014
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Padmanabh P. Bhatt, Argaw Kidane, Kevin Edwards
  • Osmotic drug delivery system
    Patent number: 8747897
    Abstract: An oral osmotic pharmaceutical delivery system comprises a highly water-soluble drug exhibiting an erratic or an incomplete release profile when formulated in a elementary osmotic pump delivery system and at least one release enhancing agent.
    Type: Grant
    Filed: April 27, 2006
    Date of Patent: June 10, 2014
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Argaw Kidane, Padmanabh P. Bhatt
  • Stabilized formulations of CNS compounds
    Patent number: 8748472
    Abstract: Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone.
    Type: Grant
    Filed: March 30, 2011
    Date of Patent: June 10, 2014
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Rong-Kun Chang, Michael L. Vieira, Likan Liang, Padmanabh P. Bhatt, Austin B. Huang, Sachin V. Patel
  • MODIFIED RELEASE PREPARATIONS CONTAINING OXCARBAZEPINE AND DERIVATIVES THEREOF
    Publication number: 20140100219
    Abstract: Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.
    Type: Application
    Filed: December 11, 2013
    Publication date: April 10, 2014
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Padmanabh P. Bhatt, Argaw Kidane, Kevin Edwards
  • Sustained-release formulations of topiramate
    Patent number: 8663683
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Grant
    Filed: August 27, 2012
    Date of Patent: March 4, 2014
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • CONTROLLED RELEASE COMPOSITIONS OF GAMMA-HYDROXYBUTYRATE
    Publication number: 20140037745
    Abstract: The present invention is directed to oral pulse-release pharmaceutical dosage form containing an immediate release component of gamma-hydroxybutyric acid, and one or more delayed/controlled release components of gamma-hydroxybutyric acid.
    Type: Application
    Filed: September 24, 2013
    Publication date: February 6, 2014
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Niraj Shah, Padmanabh P. Bhatt, Scott Ibrahim
  • Modified release preparations containing oxcarbazepine and derivatives thereof
    Patent number: 8617600
    Abstract: Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.
    Type: Grant
    Filed: May 21, 2012
    Date of Patent: December 31, 2013
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Padmanabh P. Bhatt, Argaw Kidane, Kevin Edwards
  • Controlled release compositions of gamma-hydroxybutyrate
    Patent number: 8598191
    Abstract: The present invention is directed to oral pulse-release pharmaceutical dosage form containing an immediate release component of gamma-hydroxybutyric acid, and one or more delayed/controlled release components of gamma-hydroxybutyric acid.
    Type: Grant
    Filed: May 21, 2012
    Date of Patent: December 3, 2013
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Niraj Shah, Padmanabh P. Bhatt, Scott Ibrahim
  • FORMULATIONS OF MAZINDOL
    Publication number: 20130011483
    Abstract: Formulations of mazindol having superior stability and methods of administering same are provided. The formulations may be immediate, enhanced, or otherwise delayed release formulations of mazindol.
    Type: Application
    Filed: March 30, 2011
    Publication date: January 10, 2013
    Inventors: Argaw Kidane, Padmanabh P. Bhatt
  • SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE
    Publication number: 20120321708
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Application
    Filed: August 27, 2012
    Publication date: December 20, 2012
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • Sustained-release formulations of topiramate
    Patent number: 8298580
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: October 30, 2012
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • Sustained-release formulations of topiramate
    Patent number: 8298576
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Grant
    Filed: November 16, 2007
    Date of Patent: October 30, 2012
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • CONTROLLED RELEASE COMPOSITIONS OF GAMMA-HYDROXYBUTYRATE
    Publication number: 20120231085
    Abstract: The present invention is directed to oral pulse-release pharmaceutical dosage form containing an immediate release component of gamma-hydroxybutyric acid, and one or more delayed/controlled release components of gamma-hydroxybutyric acid.
    Type: Application
    Filed: May 21, 2012
    Publication date: September 13, 2012
    Inventors: Likan Liang, Niraj Shah, Padmanabh P. Bhatt, Scott Ibrahim